BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 11939258)

  • 1. Immunosuppressive treatment of acquired aplastic anemia and immune-mediated bone marrow failure syndromes.
    Young NS
    Int J Hematol; 2002 Feb; 75(2):129-40. PubMed ID: 11939258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and Treatment of Aplastic Anemia.
    Peslak SA; Olson T; Babushok DV
    Curr Treat Options Oncol; 2017 Nov; 18(12):70. PubMed ID: 29143887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired aplastic anemia.
    Young NS
    Ann Intern Med; 2002 Apr; 136(7):534-46. PubMed ID: 11926789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current concepts in the pathophysiology and treatment of aplastic anemia.
    Young NS; Calado RT; Scheinberg P
    Blood; 2006 Oct; 108(8):2509-19. PubMed ID: 16778145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive therapies in the management of acquired immune-mediated marrow failures.
    Risitano AM
    Curr Opin Hematol; 2012 Jan; 19(1):3-13. PubMed ID: 22143074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
    Rosenfeld S; Follmann D; Nunez O; Young NS
    JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive therapy for transplant-ineligible aplastic anemia patients.
    Schrezenmeier H; Körper S; Höchsmann B
    Expert Rev Hematol; 2015 Feb; 8(1):89-99. PubMed ID: 25572607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.
    Crump M; Larratt LM; Maki E; Curtis JE; Minden MD; Meharchand JM; Lipton JH; Messner HA
    Am J Med; 1992 Jun; 92(6):596-602. PubMed ID: 1605140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aplastic anaemia.
    Brodsky RA; Jones RJ
    Lancet; 2005 May 7-13; 365(9471):1647-56. PubMed ID: 15885298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aplastic anemia.
    Storb R
    J Intraven Nurs; 1997; 20(6):317-22. PubMed ID: 9423394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe aplastic anemia and allogeneic hematopoietic stem cell transplantation.
    Myer SA; Oliva J
    AACN Clin Issues; 2002 May; 13(2):169-91. PubMed ID: 12011591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances and Long-Term Results of Medical Treatment of Acquired Aplastic Anemia: Are Patients Cured?
    Scheinberg P
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):609-618. PubMed ID: 30047414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.
    Dunn DE; Tanawattanacharoen P; Boccuni P; Nagakura S; Green SW; Kirby MR; Kumar MS; Rosenfeld S; Young NS
    Ann Intern Med; 1999 Sep; 131(6):401-8. PubMed ID: 10498555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive therapy for patients with Down syndrome and idiopathic aplastic anemia.
    Suzuki K; Muramatsu H; Okuno Y; Narita A; Hama A; Takahashi Y; Yoshida M; Horikoshi Y; Watanabe K; Kudo K; Kojima S
    Int J Hematol; 2016 Jul; 104(1):130-3. PubMed ID: 27107757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive therapy for aplastic anemia: indications, agents, mechanisms, and results.
    Camitta BM; Doney K
    Am J Pediatr Hematol Oncol; 1990; 12(4):411-24. PubMed ID: 2285122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cutting edge of aplastic anemia treatment].
    Obara N
    Rinsho Ketsueki; 2017; 58(10):1851-1859. PubMed ID: 28978824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival in severe acquired aplastic anemia of childhood.
    Fouladi M; Herman R; Rolland-Grinton M; Jones-Wallace D; Blanchette V; Calderwood S; Doyle J; Halperin D; Leaker M; Saunders EF; Zipursky A; Freedman MH
    Bone Marrow Transplant; 2000 Dec; 26(11):1149-56. PubMed ID: 11149724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
    Doney K; Leisenring W; Storb R; Appelbaum FR
    Ann Intern Med; 1997 Jan; 126(2):107-15. PubMed ID: 9005744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired aplastic anemia in Korean children: treatment guidelines from the Bone Marrow Failure Committee of the Korean Society of Pediatric Hematology Oncology.
    Kook H; Chung NG; Kang HJ; Im HJ
    Int J Hematol; 2016 Apr; 103(4):380-6. PubMed ID: 26894608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.